BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3077098)

  • 1. Further clinical and pharmacokinetic observations on the new anticonvulsant, oxcarbazepine.
    Dickinson RG; Hooper WD; Pendlebury SC; Moses D; Eadie MJ
    Clin Exp Neurol; 1988; 25():127-33. PubMed ID: 3077098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant.
    Hooper WD; Dickinson RG; Dunstan PR; Pendlebury SC; Eadie MJ
    Clin Exp Neurol; 1987; 24():105-12. PubMed ID: 3268334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyponatraemia during oxcarbazepine therapy.
    Pendlebury SC; Moses DK; Eadie MJ
    Hum Toxicol; 1989 Sep; 8(5):337-44. PubMed ID: 2680897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study.
    Wegner I; Wilhelm AJ; Sander JW; Lindhout D
    Epilepsy Behav; 2013 Oct; 29(1):217-21. PubMed ID: 23995050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience.
    Sachdeo R; Sathyan RR
    Curr Med Res Opin; 2005 Jul; 21(7):1065-8. PubMed ID: 16004674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics and indications of oxcarbazepine].
    Herranz JL; Argumosa A
    Rev Neurol; 2002 Sep; 35 Suppl 1():S101-9. PubMed ID: 12373662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases.
    Leinonen E; Lepola U; Koponen H
    Pharmacopsychiatry; 1996 Jul; 29(4):156-8. PubMed ID: 8858715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine.
    Beydoun A; Kutluay E
    Expert Opin Pharmacother; 2002 Jan; 3(1):59-71. PubMed ID: 11772334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine.
    Jensen PK; Gram L; Schmutz M
    Epilepsy Res Suppl; 1991; 3():135-40. PubMed ID: 1777069
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites.
    Mogensen PH; Jórgensen L; Boas J; Dam M; Vesterager A; Flesch G; Jensen PK
    Acta Neurol Scand; 1992 Jan; 85(1):14-7. PubMed ID: 1546529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy.
    Rey E; Bulteau C; Motte J; Tran A; Sturm Y; D'Souza J; Markabi S; Pons G; Dulac O
    J Clin Pharmacol; 2004 Nov; 44(11):1290-300. PubMed ID: 15496647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical development outlook of oxcarbazepine.
    Schwabe S
    Epilepsia; 1994; 35 Suppl 3():S2-4. PubMed ID: 8156975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.
    Mazzucchelli I; Onat FY; Ozkara C; Atakli D; Specchio LM; Neve AL; Gatti G; Perucca E
    Epilepsia; 2006 Mar; 47(3):504-9. PubMed ID: 16529613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine.
    Clinckers R; Smolders I; Meurs A; Ebinger G; Michotte Y
    Neurosci Lett; 2005 Dec; 390(1):48-53. PubMed ID: 16139430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent oxcarbazepine-related anorgasmia.
    Calabrò RS; Ferlazzo E; Italiano D; Bramanti P
    Epilepsy Behav; 2010 Feb; 17(2):287-8. PubMed ID: 20089459
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxcarbazepine: new preparation. An alternative to carbamazepine in partial epilepsy.
    Prescrire Int; 2001 Dec; 10(56):170-4. PubMed ID: 11824439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with oxcarbazepine.
    Gram L
    Epilepsia; 1994; 35 Suppl 3():S21-2. PubMed ID: 8156976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.